Literature DB >> 25595743

Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care.

Daniel B Klein1, Wendy A Leyden2, Lanfang Xu3, Chun R Chao3, Michael A Horberg4, William J Towner5, Leo B Hurley2, Julia L Marcus2, Charles P Quesenberry2, Michael J Silverberg2.   

Abstract

Concerns remain for an increased myocardial infarction (MI) risk among individuals infected with human immunodeficiency virus (HIV). We conducted a cohort study evaluating MI risk from 1996 to 2011 by HIV status. The adjusted MI rate ratio for HIV status declined over time, reaching 1.0 (95% confidence interval, .7-1.4) in 2010-2011, the most recent study period.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; myocardial infarction; secular trend

Mesh：

Year:  2015        PMID： 25595743     DOI： 10.1093/cid/civ014

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  58 in total

1.  Communicable and non-communicable diseases: connections, synergies and benefits of integrating care.

Authors:  A D Harries; A M V Kumar; S Satyanarayana; Y Lin; K C Takarinda; H Tweya; A J Reid; R Zachariah
Journal:  Public Health Action       Date:  2015-09-21

Review 2.  Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults.

Authors:  Robert C Kaplan; David B Hanna; Jorge R Kizer
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

Review 3.  Inflammation, immune activation, and cardiovascular disease in HIV.

Authors:  Eric Nou; Janet Lo; Steven K Grinspoon
Journal:  AIDS       Date:  2016-06-19       Impact factor: 4.177

Review 4.  Managing HIV infection in patients older than 50 years.

Authors:  Jacqueline M McMillan; Hartmut Krentz; M John Gill; David B Hogan
Journal:  CMAJ       Date:  2018-10-22       Impact factor: 8.262

Review 5.  Cardiovascular Complications of HIV in Endemic Countries.

Authors:  Matthew J Feinstein; Milana Bogorodskaya; Gerald S Bloomfield; Rajesh Vedanthan; Mark J Siedner; Gene F Kwan; Christopher T Longenecker
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931

Review 6.  Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?

Authors:  Shima Shahbaz; Marcella Manicardi; Giovanni Guaraldi; Paolo Raggi
Journal:  World J Cardiol       Date:  2015-10-26

7.  Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy.

Authors:  Kassem Bourgi; Peter F Rebeiro; Megan Turner; Jessica L Castilho; Todd Hulgan; Stephen P Raffanti; John R Koethe; Timothy R Sterling
Journal:  Clin Infect Dis       Date:  2020-03-17       Impact factor: 9.079

8.  Novel mediators of statin effects on plaque in HIV: a proteomics approach.

Authors:  Chris deFilippi; Janet Lo; Robert Christenson; Ida Grundberg; Lauren Stone; Markella V Zanni; Hang Lee; Steven K Grinspoon
Journal:  AIDS       Date:  2018-04-24       Impact factor: 4.177

Review 9.  HIV and Cardiovascular Disease: Update on Clinical Events, Special Populations, and Novel Biomarkers.

Authors:  Kaku So-Armah; Matthew S Freiberg
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

Review 10.  Immune activation and cardiovascular disease in chronic HIV infection.

Authors:  Chris T Longenecker; Claire Sullivan; Jason V Baker
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.